Likewise, LRP1-mediated internalization of SERPINE2/PN-1 inhibits SHH ligand-dependent signaling in human prostate adenocarcinoma cells, which results in down-regulation of SHH and GLI1 expression [36]. Here, SERPINE2 is linked to prostate adenocarcinoma.